http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2274060
Outgoing Links
| Predicate | Object |
|---|---|
| contentType | Journal Article |
| endingPage | 8 |
| issn | 1369-7056 |
| issueIdentifier | 2 |
| pageRange | 154-8 |
| publicationName | IDrugs : the investigational drugs journal |
| startingPage | 154 |
| bibliographicCitation | Zhang X. Inhibitors of hepatitis C--a review of the recent patent literature. IDrugs. 2002 Feb;5(2):154–8. PMID: 12861476. |
| creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9450f169111b16a697b1c9b7b638e109 |
| date | 200202 |
| identifier | https://pubmed.ncbi.nlm.nih.gov/12861476 |
| isPartOf | https://portal.issn.org/resource/ISSN/1369-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30361 |
| language | English |
| source | https://pubmed.ncbi.nlm.nih.gov/ |
| title | Inhibitors of hepatitis C--a review of the recent patent literature |
| discussesAsDerivedByTextMining | http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7996 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_384415490916d74a6c3bfe6d50a4ef9b |
Incoming Links
Total number of triples: 30.